NZ Colorectal Oncology Research Review Issue 41

In this issue:
  -  Encorafenib, cetuximab and chemotherapy in BRAF-mutant CRC
  -  Circulating tumour DNA analysis guiding adjuvant therapy in colon cancer
  -  Lymph node yield and long-term mortality risk in colon cancer
  -  KH903 + FOLFIRI in unresectable recurrent or metastatic CRC
  -  Early discontinuation of immunotherapy in mCRC
  -  Overall survival with sotorasib + panitumumab in KRAS G12C CRC
  -  Retifanlimab for metastatic SCC of the anal canal
  -  When should CRC screening begin?
  -  CRC incidence trends in younger vs older adults
  -  Geographic and age variations in mutational processes in CRC

Please login below to download this issue (PDF)

Subscribe